140 related articles for article (PubMed ID: 23956224)
1. The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group.
Ho PA; Alonzo TA; Gerbing RB; Kuhn J; Pollard JA; Hirsch B; Raimondi SC; Gamis AS; Meshinchi S
Pediatr Blood Cancer; 2014 Jan; 61(1):81-8. PubMed ID: 23956224
[TBL] [Abstract][Full Text] [Related]
2. WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.
Ho PA; Kuhn J; Gerbing RB; Pollard JA; Zeng R; Miller KL; Heerema NA; Raimondi SC; Hirsch BA; Franklin JL; Lange B; Gamis AS; Alonzo TA; Meshinchi S
J Clin Oncol; 2011 Feb; 29(6):704-11. PubMed ID: 21189390
[TBL] [Abstract][Full Text] [Related]
3. Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.
Junghanns AS; Wittig S; Woehlecke C; Lehmann T; Arndt C; Gruhn B
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2221-8. PubMed ID: 26224397
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Prognostic Impact of Wilms' Tumor 1 (WT1) Gene, Including SNP rs16754 in Cytogenetically Normal Acute Myeloblastic Leukemia (CN-AML): An Iranian Experience.
Toogeh G; Ramzi M; Faranoush M; Amirizadeh N; Haghpanah S; Moghadam M; Cohan N
Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e21-6. PubMed ID: 26725263
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
Damm F; Heuser M; Morgan M; Yun H; Grosshennig A; Göhring G; Schlegelberger B; Döhner K; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar A; Fiedler W; Kirchner H; Döhner H; Heil G; Ganser A; Krauter J
J Clin Oncol; 2010 Feb; 28(4):578-85. PubMed ID: 20038731
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Becker H; Maharry K; Radmacher MD; Mrózek K; Metzeler KH; Whitman SP; Schwind S; Kohlschmidt J; Wu YZ; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Moore JO; Caligiuri MA; Larson RA; Marcucci G; Bloomfield CD
Haematologica; 2011 Oct; 96(10):1488-95. PubMed ID: 21659357
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphism of Wilms' tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia.
Choi Y; Lee JH; Hur EH; Kang MJ; Kim SD; Lee JH; Kim DY; Lim SN; Bae KS; Lim HS; Seol M; Kang YA; Lee KH
Ann Hematol; 2012 May; 91(5):671-677. PubMed ID: 22015946
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia.
Petiti J; Rosso V; Lo Iacono M; Calabrese C; Signorino E; Gaidano V; Berger M; Saglio G; Cilloni D
Leuk Res; 2018 Apr; 67():6-11. PubMed ID: 29407184
[TBL] [Abstract][Full Text] [Related]
9. WT1 mutations and single nucleotide polymorphism rs16754 analysis of patients with pediatric acute myeloid leukemia in a Chinese population.
Chen X; Yang Y; Huang Y; Tan J; Chen Y; Yang J; Dou H; Zou L; Yu J; Bao L
Leuk Lymphoma; 2012 Nov; 53(11):2195-204. PubMed ID: 22506617
[TBL] [Abstract][Full Text] [Related]
10. Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study.
Hidaka D; Onozawa M; Hashiguchi J; Miyashita N; Kasahara K; Fujisawa S; Hayase E; Okada K; Shiratori S; Goto H; Sugita J; Nakagawa M; Hashimoto D; Kahata K; Endo T; Yamamoto S; Tsutsumi Y; Haseyama Y; Nagashima T; Mori A; Ota S; Sakai H; Ishihara T; Imai K; Miyagishima T; Kakinoki Y; Kurosawa M; Kobayashi H; Iwasaki H; Shimizu C; Kondo T; Teshima T
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e469-e479. PubMed ID: 30082223
[TBL] [Abstract][Full Text] [Related]
11. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
[TBL] [Abstract][Full Text] [Related]
12. Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 in de novo non-M3 acute myeloid leukemia.
Luo S; Yu K; Yan QX; Shen ZJ; Wu JB; Chen HM; Gao SM
Leuk Lymphoma; 2014 Feb; 55(2):349-57. PubMed ID: 23550990
[TBL] [Abstract][Full Text] [Related]
13. The Wilms Tumor-1 (WT1) rs16754 polymorphism is a prognostic factor in acute myeloid leukemia (AML): a meta-analysis.
Long J; Fang S; Dai Q; Liu X; Zhu W; Wang S
Oncotarget; 2016 May; 7(22):32079-87. PubMed ID: 26992216
[TBL] [Abstract][Full Text] [Related]
14. Association between the Wilms tumor-1 rs16754 polymorphism and acute myeloid leukemia: A MOOSE-compliant meta-analysis.
Yu X; Zhang Y; Liu S; Mu Y; Shang F; Zhang N
Medicine (Baltimore); 2020 Jul; 99(27):e20713. PubMed ID: 32629644
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma.
Li X; Wang S; Sitaram RT; Andersson C; Ljungberg B; Li A
PLoS One; 2013; 8(3):e58396. PubMed ID: 23484026
[TBL] [Abstract][Full Text] [Related]
16. Wilms Tumor 1 rs16754 predicts favorable clinical outcomes for acute myeloid leukemia patients in South Chinese population.
Zhang DY; Yan H; Cao S; Zhang W; Li XL; Zeng H; Chen XP
Leuk Res; 2015 Jun; 39(6):568-74. PubMed ID: 25841655
[TBL] [Abstract][Full Text] [Related]
17. The Wilms Tumor-1 (WT1) rs2234593 variant is a prognostic factor in normal karyotype acute myeloid leukemia.
Niavarani A; Horswell S; Sadri R; Bonnet D
Ann Hematol; 2016 Jan; 95(2):179-90. PubMed ID: 26499507
[TBL] [Abstract][Full Text] [Related]
18. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.
Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y
Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Ho PA; Zeng R; Alonzo TA; Gerbing RB; Miller KL; Pollard JA; Stirewalt DL; Heerema NA; Raimondi SC; Hirsch B; Franklin JL; Lange B; Meshinchi S
Blood; 2010 Aug; 116(5):702-10. PubMed ID: 20413658
[TBL] [Abstract][Full Text] [Related]
20. Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.
Pollard JA; Alonzo TA; Loken M; Gerbing RB; Ho PA; Bernstein ID; Raimondi SC; Hirsch B; Franklin J; Walter RB; Gamis A; Meshinchi S
Blood; 2012 Apr; 119(16):3705-11. PubMed ID: 22378848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
